2022년 8월 23일 17:00

Miracor Medical Announces FDA IDE Approval For PiCSO® Pivotal Study

Miracor Medical SA (Miracor Medical) has announced the approval of an Investigational Device Exemption (IDE) from the FDA, enabling the company to initiate a pivotal study with its Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) ...